Prof Deborah Marsh: Ubiquitin, the epigenome and tumour suppressors – shaping the cancer chromatin and gene expression landscape
Centre for Cancer Research Seminar
Location:WIMR Conference Rooms, level 2
Prof Deborah Marsh from the Kolling Institute: Ubiquitin, the epigenome and tumour suppressors – shaping the cancer chromatin and gene expression landscape
After completing her undergrad and PhD from University of Sydney on familial endocrine cancers, Prof Deborah Marsh, moved to Boston to carry out her post-doctoral studies at the Dana Faber Cancer Institute for 3 years. She came back to USyd and the Kolling Institute, where she is currently a Prof of Molecular Oncology. She served on the editorial board for Cancer Letters for over 15 years and is currently an associate editor for the journal Endocrine-related cancer.
The Functional Genomics Laboratory which she heads is part of the Hormones and Cancer division of Kolling and their area of focus is to understand cellular processes, including resistance to chemotherapy, epigenomics in ovarian cancer, histone proteins and non-coding RNAs influencing gene expression. Prof Deborah Marsh is also part of the INNOVATe program, which facilitates personalised treatment based on precision medicine for women with ovarian cancer.